Hearing: Examining Drug Compounding

Subcommittee on Health (Committee on Energy and Commerce)

Thursday, May 23, 2013 (10:00 AM)

2322 RHOB
Washington, D.C. 20515-20515

Witnesses

Panel one

Dr. Janet Woodcock
Director, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD

Added 05/21/2013 at 09:07 AM
  • Witness Statement [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Invitation [PDF] Added 10/18/2013 at 01:49 PM
  • Questions for the Record letter [PDF] Added 10/18/2013 at 01:49 PM
  • Questions for the Record response [PDF] Added 04/03/2014 at 05:21 PM
  • Witness Truth in Testimony [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Biography [PDF] Added 10/18/2013 at 01:49 PM

Panel two

Ms. Gabrielle Cosel
Project Manager, Drug Safety Project, The Pew Charitable Trusts, Washington, D.C.

Added 05/21/2013 at 09:07 AM
  • Witness Statement [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Invitation [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Truth in Testimony [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Biography [PDF] Added 10/18/2013 at 01:49 PM

Dr. Scott Gottlieb
Resident Fellow, American Enterprise Institute, Washington, D.C.

Added 05/21/2013 at 09:07 AM
  • Witness Statement [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Invitation [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Truth in Testimony [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Biography [PDF] Added 10/18/2013 at 01:49 PM

Dr. Joseph H. Harmison
Owner, Harmison Pharmacies, Arlington, TX, on behalf of National Community Pharmacists Association

Added 05/21/2013 at 09:07 AM
  • Witness Statement [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Invitation [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Truth in Testimony [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Biography [PDF] Added 10/18/2013 at 01:49 PM

Ms. Gerald P. Migliaccio
Quality Systems Consultant, Migliaccio Consulting, Essex, CT

Added 05/21/2013 at 09:07 AM
  • Witness Statement [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Invitation [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Truth in Testimony [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Biography [PDF] Added 10/18/2013 at 01:49 PM

Ms. Elizabeth Scott Russell
Government Affairs Manager, National Association of Boards of Pharmacy, Mount Prospect, IL

Added 05/21/2013 at 09:07 AM
  • Witness Statement [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Invitation [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Truth in Testimony [PDF] Added 10/18/2013 at 01:49 PM
  • Witness Biography [PDF] Added 10/18/2013 at 01:49 PM

Support Documents

  • Hearing Notice [PDF]
  • Hearing Memo [PDF] Added 05/21/2013 at 09:07 AM
  • Opening Statement of Subcommittee Chairman Pitts [PDF] Added 06/03/2013 at 03:53 PM
  • Opening Statement of Chairman Emeritus Barton [PDF] Added 06/03/2013 at 03:53 PM
  • Attendance [PDF] Added 06/03/2013 at 03:53 PM
  • Document for the Record, a letter from Mr. Dingell on October 9, 2012 to the FDA [PDF] Added 06/03/2013 at 03:53 PM
  • Document for the Record, a letter from Mr. Dingell on October 16, 2012 to FDA [PDF] Added 06/03/2013 at 03:53 PM
  • Document for the Record from NACDS [PDF] Added 06/03/2013 at 03:53 PM
  • Document for the Record from CAPS [PDF] Added 06/03/2013 at 03:53 PM
  • Document for the Record, a response from FDA to Mr. Dingell's October 9, 2012 letter [PDF] Added 06/03/2013 at 03:53 PM
  • Document for the Record, a response from FDA to Mr. Dingell's October 16, 2012 letter [PDF] Added 06/03/2013 at 03:53 PM

Hearing Record

  • Hearing Transcript [PDF] Added 10/18/2013 at 01:49 PM

First Published: May 16, 2013 at 05:22 PM
Last Updated: April 3, 2014 at 05:21 PM